DOCSLIB.ORG

Nanotechnology for Regenerative Medicine: Nanomaterials for Stem Cell Imaging

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Nanotechnology for Regenerative Medicine: Nanomaterials for Stem Cell Imaging REVIEW Nanotechnology for regenerative medicine: nanomaterials for stem cell imaging Aniruddh Solanki1, Although stem cells hold great potential for the treatment of many injuries and John D Kim1 & degenerative diseases, several obstacles must be overcome before their therapeutic Ki-Bum Lee1,2,3† application can be realized. These include the development of advanced techniques to †Author for correspondence 1Rutgers, The State University understand and control functions of microenvironmental signals and novel methods to of New Jersey, Department of track and guide transplanted stem cells. The application of nanotechnology to stem cell Chemistry & Chemical biology would be able to address those challenges. This review details the current Biology, Piscataway, NJ 08854, USA challenges in regenerative medicine, the current applications of nanoparticles in stem cell 2Institute for Advanced biology and further potential of nanotechnology approaches towards regenerative Materials, Devices & medicine, focusing mainly on magnetic nanoparticle- and quantum dot-based applications Nanotechnology, 607 Taylor in stem cell research. Road, Piscataway, NJ 08854, USA 3The Rutgers Stem Cell Why nanotechnology for microenvironments. Conventional experimental Research Center, Rutgers, regenerative medicine? The State University of New studies for specific cellular responses are typically Jersey, Piscataway, NJ 08854, The recent emergence of nanotechnology has set conducted on large cell populations, which inev- USA high expectations in biological science and medi- itably produce data measured from an inhomo- Tel.: +1 732 445 0281; cine; many scientists now predict that nanotech- geneous distribution of cellular responses. Unless Fax: +1 732 445 5312; E-mail: [email protected] nology can solve many key questions concerning cellular responses and processes are isolated from biological systems that transpire at the nanoscale. inhomogeneous signals at the single cell level, it Nanomedicine, defined broadly as the approach of would be extremely difficult to elucidate the science and engineering at the nanometer scale intricate cellular systems and to analyze the com- towards biomedical applications, has been drawing plex dynamic signaling transductions. Further- considerable attention in the area of nanotechnol- more, conventional biomedical approaches reveal ogy [1]. Given that the sizes of functional elements very little concerning genotypic aspects that tran- in biology are in the nanometer scale range, it is scend into cell phenotypes. Thus, to better not surprising that nanomaterials interact with understand and control the responses of cells biological systems at the molecular level [2]. In towards external stimuli at the single cell or sin- addition, nanomaterials have novel electronic, gle molecule level, it is imperative to characterize optical, magnetic and structural properties that the full range of cell behaviors (e.g., self-renewal, cannot be obtained from either individual mole- differentiation, migration and apoptosis). cules or bulk materials. These unique features can Recently, stem cells have gained much atten- be tuned precisely to explore biological phenom- tion for the treatment of devastating injuries ena through numerous innovative techniques. and damage caused by degenerative diseases, One of the major goals of biology is to address the diabetes and aging [4]. Stem cells self-renew for spatial–temporal interactions of biomolecules at long periods of time and then further differenti- the cellular and integrated systems level [3]. How- ate into specialized cells and tissues on stimula- ever, to apply nanotechnology to biology and tion by appropriate microenvironmental cues. medicine, several conditions must be considered: They are typically categorized as embryonic • Nanomaterials must be designed to interact stem cells (ESCs) or tissue-specific adult stem with proteins and cells without interfering cells, depending on their origin and differentia- with their biological activities tion capability. ESCs, which originate from the inner-cell mass of the blastocyst-stage embryo, • Nanomaterials must maintain their physical Keywords: magnetic are able to differentiate into all cell lineages nanoparticle, quantum dots, properties after surface modification regenerative medicine, stem found in the three primary germ layers of the cell imaging • Nanomaterials must be nontoxic embryo (e.g., endoderm, mesoderm and ecto- Cells are single living units of organisms that derm) [5]. Although it has been shown that part of receive the input signals from disease and injury human ESCs (hESCs) can differentiate into and then return the output signals to their many interesting cell types, such as cells of 10.2217/17435889.3.4.567 © 2008 Future Medicine Ltd ISSN 1743-5889 Nanomedicine (2008) 3(4), 567–578 567 REVIEW – Solanki, Kim & Lee heart, brain or bone [5], the therapeutic poten- Nanomaterials for molecular tial of hESCs has not been fully realized owing & cellular imaging to numerous restrictions, including biological Although nanoparticles can be synthesized from issues concerning immunogenicity and rejection various materials using several methods, the cou- and social issues concerning ethics and pling and functionalization of nanoparticles with morality [6,7]. Adult stem/progenitor cells (e.g., biomolecules should be carried out in controlled mesenchymal [MSCs], hematopoietic and neu- conditions, such as a specific salt concentration ral stem cells [NSCs]) reside in mature tissue or pH. For this purpose, interdisciplinary knowl- compartments and are known to function as the edge from molecular biology, bioorganic chemis- replication resources for cell renewal during nor- try, bioinorganic chemistry and surface mal homeostasis of tissue regeneration. In con- chemistry must be used to functionalize nano- trast to ESCs, adult stem cells can only particles with biomolecules. With significant proliferate for a few passages and their differen- advancements in synthetic and modification tiation ability is limited to certain cell types, methodologies, nanomaterials can be modified depending on where they are located (e.g., bone to desired sizes, shapes, compositions and prop- marrow, brain or epithelial tissues) [8]. erties [10,11]; they can then be functionalized Intrinsic regulators (e.g., growth factors and readily with biomolecules through combined signaling molecules) and cellular microenviron- methodologies from bioorganic, bioinorganic ments, such as extracellular matrices (ECMs), and surface chemistry. are two prime factors that have critical roles in the regulation of stem cell behaviors. To harness Magnetic nanomaterials: the unique potential of stem cells, it is important iron oxide nanoparticles to understand the functions of intrinsic regula- Inorganic nanoparticles, especially iron oxide tors and extracellular microenvironments during nanoparticles and quantum dots (QDs), are stem cell fate [9]. Furthermore, to fully achieve one of the most promising materials for stem the therapeutic promise of stem cells, several cell research because they can be synthesized critical issues (Box 1) need to be addressed. easily in large quantities from various materials Nanostructures and nanomaterials can inter- using relatively simple methods. The dimen- act intrinsically with biological systems at the sions of the nanoparticles can be tuned from single molecular level with high specificity. The one to a few hundred nanometers with a mono- unique properties of nanomaterials and nano- dispersed size distribution. Moreover, they can structures can be particularly useful in control- comprise different metals, metal oxides and ling intrinsic stem cell signals and in dissecting semiconducting materials, whose compositions the mechanisms underlying embryonic and and sizes are variable. adult stem cell behavior (Figure 1). Iron oxide nanoparticles can either bind to Herein, we have summarized nanotechnology the external cell membrane or can be internal- approaches for stem cell research and have fur- ized into the cytoplasm. Particles that are ther addressed some of the challenges concerning bound externally do not affect cell viability, these research efforts. Owing to the extensive although, they may interfere with cell-surface scope of the topic and space limitations, we have interactions or may simply detach from the cell focused primarily on cellular imaging from the membrane [12]. However, iron oxide nano- numerous applications of nanotechnology in particles that can be internalized within cells stem cell biology. have their surfaces modified to ensure high uptake efficiency with minimum deleterious effects on the cells [13]. For example, coating the Box 1. Critical issues for the therapeutic applications of surface of superparamagnetic iron oxide nano- stem cells. particles (SPIONs) with dextran or other poly- • The long-term behavior of transplanted stem cells in the target tissues mers enhances stability and solubility [14] and • The pluripotency/multipotency of stem cells to differentiate towards also prevents aggregation [15]. The coated SPI- homogeneous populations of specific cell types ONs are useful for tracking and studying • The control of transplanted stem cells to migrate to the correct stem/progenitor cells with MRI. In this regard, microenvironmental places magnetic iron oxide nanoparticles and their • The tracking of transplanted stem cells by labeling techniques composites are emerging as novel contrast • The optimal time
Load more

Recommended publications
  • COVID-19 Publications - Week 05 2021 1328 Publications
    Update February 1 - February 7, 2021, Dr. Peter J. Lansberg MD, PhD Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics COVID-19 publications - Week 05 2021 1328 Publications PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected] Reliable on-line resources for Covid 19 WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap) Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With
    [Show full text]
  • Regenerative Medicine
    Growth Factors and Cellular Therapies in Clinical Musculoskeletal Medicine Douglas E. Hemler, M.D. STAR Spine & Sport Golden, CO June 13, 2016 Regenerative Medicine The term Regenerative Medicine was first coined in 1992 by Leland Kaiser1. Depending on the area of specialization, the definition varies. It is an evolving science that focuses on using components from our own bodies and external technologies to restore and rebuild our own tissues without surgery2. Closely related to Regenerative Medicine is a forward looking approach called Translational Medicine or Translational Science3. As applied to Musculoskeletal Regenerative Medicine, Translational Medicine is the application of scientific disciplines including tissue engineers, molecule biologists, researchers, industry and practicing clinicians who merge their science and experience to develop new approaches to healing tendons and joints. Some aspects of the field are highly complex, confined to laboratories and research institutions such as organ regeneration and embryonic stem cell research. Other areas are ready for clinical application. As defined by the European Society for Translational Medicine (EUSTM) it is an interdisciplinary branch of the biomedical field supported by three main pillars: bench side, bedside and community. The bench to bedside model includes transitioning clinical research to community practice using interactive science and data to benefit the community as a whole. Translational Medicine can be as complex as the research into total organ regeneration, total replacement of blood cell systems following cancer chemotherapy, or the scientific and ethical ramifications of embryonic stem cell research.45 Out of these efforts have come a group of therapies that are being applied by forward looking musculoskeletal practices such as STAR Spine and Sport.
    [Show full text]
  • Design and Characterization of Inulin Conjugate for Improved Intracellular and Targeted Delivery of Pyrazinoic Acid to Monocytes
    pharmaceutics Article Design and Characterization of Inulin Conjugate for Improved Intracellular and Targeted Delivery of Pyrazinoic Acid to Monocytes Franklin Afinjuomo 1, Thomas G. Barclay 1, Ankit Parikh 1, Yunmei Song 1, Rosa Chung 1, Lixin Wang 1, Liang Liu 1, John D. Hayball 1, Nikolai Petrovsky 2,3 and Sanjay Garg 1,* 1 School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA 5001, Australia; olumide.afi[email protected] (F.A.); [email protected] (T.G.B.); [email protected] (A.P.); [email protected] (Y.S.); [email protected] (R.C.); [email protected] (L.W.); [email protected] (L.L.); [email protected] (J.D.H.) 2 Vaxine Pty. Ltd., Adelaide, SA 5042, Australia; nikolai.petrovsky@flinders.edu.au 3 Department of Endocrinology, Flinders University, Adelaide, SA 5042, Australia * Correspondence: [email protected]; Tel.: +61-8-8302-1567 Received: 26 April 2019; Accepted: 16 May 2019; Published: 22 May 2019 Abstract: The propensity of monocytes to migrate into sites of mycobacterium tuberculosis (TB) infection and then become infected themselves makes them potential targets for delivery of drugs intracellularly to the tubercle bacilli reservoir. Conventional TB drugs are less effective because of poor intracellular delivery to this bacterial sanctuary. This study highlights the potential of using semicrystalline delta inulin particles that are readily internalised by monocytes for a monocyte-based drug delivery system. Pyrazinoic acid was successfully attached covalently to the delta inulin particles via a labile linker.
    [Show full text]
  • Advances in Nanomaterials in Biomedicine
    nanomaterials Editorial Advances in Nanomaterials in Biomedicine Elena Ryabchikova Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Science, 8 Lavrentiev Ave., 630090 Novosibirsk, Russia; [email protected] Keywords: nanotechnology; nanomedicine; biocompatible nanomaterials; diagnostics; nanocarriers; targeted drug delivery; tissue engineering Biomedicine is actively developing a methodological network that brings together biological research and its medical applications. Biomedicine, in fact, is at the front flank of the creation of the latest technologies for various fields in medicine, and, obviously, nanotechnologies occupy an important place at this flank. Based on the well-known breadth of the concept of “Biomedicine”, the boundaries of the Special Issue “Advances in Nanomaterials in Biomedicine” were not limited, and authors could present their work from various fields of nanotechnology, as well as new methods and nanomaterials intended for medical applications. This approach made it possible to make public not only specific developments, but also served as a kind of mirror reflecting the most active interest of researchers in a particular field of application of nanotechnology in biomedicine. The Special Issue brought together more than 110 authors from different countries, who submitted 11 original research articles and 7 reviews, and conveyed their vision of the problems of nanomaterials in biomedicine to the readers. A detailed and well-illustrated review on the main problems of nanomedicine in onco-immunotherapy was presented by Acebes-Fernández and co-authors [1]. It should be noted that the review is not limited to onco-immunotherapy, and gives a complete understanding of nanomedicine in general, which is useful for those new to this field.
    [Show full text]
  • The Future of Tissue Engineering and Regenerative Medicine in the African Continent
    Department of Biomedical Sciences Faculty of Science THE FUTURE OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE IN THE AFRICAN CONTINENT • DR KEOLEBOGILE MOTAUNG • TSHWANE UNIVERSITY OF TECHNOLOGY • DEPARTMENT OF BIOMEDICAL SCIENCES • TSHWANE • SOUTH AFRICA 1 Department of Biomedical Sciences Faculty of Science OUTLINE • Definition of TE and RM • Applications and Benefits • Research work • Challenges • Recommendations to improve gender content and social responsibility of research programmes in Africa that can enhance the effectiveness and sustainability of the development measures needed 2 Department of Biomedical Sciences Faculty of Science QUESTIONS ? How can one create human spare parts that has been damaged? Why do we have to create spare parts? 3 Department of Biomedical Sciences Faculty of Science HOW? TISSUE ENGINEERING AND REGENERATIVE MEDICINE • Is as science of design and manufacture of new tissues for the functional restoration of impaired organs and replacement of lost parts due to cancer, diseases and trauma. • Creation of human spare parts? 4 Department of Biomedical Sciences Faculty of Science WHY? DO WE HAVE TO CREATE HUMAN SPARE PARTS? • Shortage of donor tissues and organs • Survival rates for major organ transplantations are poor despite their high costs and the body's immune system often rejects donated tissue and organs. • Tissue engineering and Regenerative Medicine therefore, has remarkable potential in the medical field to solve these problems 5 Department of Biomedical Sciences Faculty of Science APPLICATIONS:
    [Show full text]
  • Regenerative Medicine Options for Chronic Musculoskeletal Conditions: a Review of the Literature Sean W
    Regenerative Medicine Options for Chronic Musculoskeletal Conditions: A Review of the Literature Sean W. Mulvaney, MD1; Paul Tortland, DO2; Brian Shiple, DO3; Kamisha Curtis, MPH4 1 Associate Professor of Medicine, Uniformed Services expected to be over 67 billion dollars in spending on University, Bethesda, MD biologics and cell therapies by 2020 (1). 2 FAOASM, Associate Clinical Professor of Medicine, University of Connecticut, Farmington, CT Specifically, regenerative medicine also stands 3 CAQSM, RMSK, ARDMS; The Center for Sports Medicine & in contrast to treatment modalities that impair Wellness, Glen Mills, PA the body’s ability to facilitate endogenous repair 4 Regenerative and Orthopedic Sports Medicine, Annapolis, MD mechanisms such as anti-inflammatory drugs (2,3); destructive modalities (e.g., radio frequency ablation of nerves, botulinum toxin injections) (4); Abstract and surgical methods that permanently alter the functioning of a joint, including joint fusion, spine egenerative medicine as applied to fixation, and partial or total arthroplasty. When musculoskeletal injuries is a term compared to other allopathic options (including knee used to describe a growing field of R and hip arthroplasty with a 90-day mortality rate of musculoskeletal medicine that concentrates 0.7% in the Western hemisphere) (5), regenerative on evidence-based treatments that focus on medicine treatment modalities have a lower and augment the body’s endogenous repair incidence of adverse events with a growing body of capabilities. These treatments are targeted statistically significant medical literature illustrating at the specific injury site or region of injury both their safety and efficacy (6). by the precise application of autologous, allogeneic or proliferative agents.
    [Show full text]
  • The Bridge Between Transplantation and Regenerative Medicine: Beginning a New Banff Classification of Tissue Engineering Pathology
    Received: 28 April 2017 | Revised: 21 November 2017 | Accepted: 24 November 2017 DOI: 10.1111/ajt.14610 PERSONAL VIEWPOINT The bridge between transplantation and regenerative medicine: Beginning a new Banff classification of tissue engineering pathology K. Solez1 | K. C. Fung1 | K. A. Saliba1 | V. L. C. Sheldon2 | A. Petrosyan3 | L. Perin3 | J. F. Burdick4 | W. H. Fissell5 | A. J. Demetris6 | L. D. Cornell7 1Department of Laboratory Medicine and Pathology, Faculty of Medicine and The science of regenerative medicine is arguably older than transplantation—the first Dentistry, University of Alberta, Edmonton, major textbook was published in 1901—and a major regenerative medicine meeting AB, Canada took place in 1988, three years before the first Banff transplant pathology meeting. 2Medical Anthropology Program, Department of Anthropology, Faculty of Arts and However, the subject of regenerative medicine/tissue engineering pathology has Sciences, University of Toronto, Toronto, never received focused attention. Defining and classifying tissue engineering pathol- Ontario, Canada ogy is long overdue. In the next decades, the field of transplantation will enlarge at 3Division of Urology GOFARR Laboratory for Organ Regenerative Research and least tenfold, through a hybrid of tissue engineering combined with existing ap- Cell Therapeutics, Children’s Hospital Los proaches to lessening the organ shortage. Gradually, transplantation pathologists will Angeles, Saban Research Institute, University of Southern California, Los Angeles, CA, USA become tissue- (re- ) engineering pathologists with enhanced skill sets to address con- 4Department of Surgery, Johns Hopkins cerns involving the use of bioengineered organs. We outline ways of categorizing ab- School of Medicine, Baltimore, MD, USA normalities in tissue- engineered organs through traditional light microscopy or other 5Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA modalities including biomarkers.
    [Show full text]
  • Introducing Bionanotechnology Into Undergraduate Biomedical Engineering
    AC 2009-504: INTRODUCING BIONANOTECHNOLOGY INTO UNDERGRADUATE BIOMEDICAL ENGINEERING Aura Gimm, Duke University J. Aura Gimm is Assistant Professor of the Practice and Associated Director of Undergraduate Studies in the Department of Biomedical Engineering at Duke University. She teaches courses in biomaterials, thermodynamics/kinetics, engineering design, and a new course in bionanotechnology. Dr. Gimm received her S.B. in Chemical Engineering and Biology from MIT, and her Ph.D. in Bioengineering from UC-Berkeley. Page 14.802.1 Page © American Society for Engineering Education, 2009 Introducing Bionanotechnology in Undergraduate Biomedical Engineering Abstract As a part of the NSF-funded Nanotechnology Undergraduate Education Program, we have developed and implemented a new upper division elective course in Biomedical Engineering titled “Introduction to Bionanotechnology Engineering”. The pilot course included five hands- on “Nanolab” modules that guided students through specific aspects of nanomaterials and engineering design in addition to lecture topics such as scaling effects, quantum effects, electrical/optical properties at nanoscale, self-assembly, nanostructures, nanofabrication, biomotors, biological designing, biosensors, etc. Students also interacted with researchers currently working in the areas of nanomedicine, self-assembly, tribiology, and nanobiomaterials to learn first-hand the engineering and design challenges. The course culminated with research or design proposals and oral presentations that addressed specific engineering/design issues facing nanobiotechnology and/or nanomedicine. The assessment also included an exam (only first offering), laboratory write-ups, reading of research journal articles and analysis, and an essay on ethical/societal implications of nanotechnology, and summative questionnaire. The course exposed students to cross-disciplinary intersections that occur between biomedical engineering, materials science, chemistry, physics, and biology when working at the nanoscale.
    [Show full text]
  • Nanotechnology in Regenerative Medicine: the Materials Side
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by UPCommons. Portal del coneixement obert de la UPC Review Nanotechnology in regenerative medicine: the materials side Elisabeth Engel, Alexandra Michiardi, Melba Navarro, Damien Lacroix and Josep A. Planell Institute for Bioengineering of Catalonia (IBEC), Department of Materials Science, Technical University of Catalonia, CIBER BBN, Barcelona, Spain Regenerative medicine is an emerging multidisciplinary structures and materials with nanoscale features that can field that aims to restore, maintain or enhance tissues mimic the natural environment of cells, to promote certain and hence organ functions. Regeneration of tissues can functions, such as cell adhesion, cell mobility and cell be achieved by the combination of living cells, which will differentiation. provide biological functionality, and materials, which act Nanomaterials used in biomedical applications include as scaffolds to support cell proliferation. Mammalian nanoparticles for molecules delivery (drugs, growth fac- cells behave in vivo in response to the biological signals tors, DNA), nanofibres for tissue scaffolds, surface modifi- they receive from the surrounding environment, which is cations of implantable materials or nanodevices, such as structured by nanometre-scaled components. Therefore, biosensors. The combination of these elements within materials used in repairing the human body have to tissue engineering (TE) is an excellent example of the reproduce the correct signals that guide the cells great potential of nanotechnology applied to regenerative towards a desirable behaviour. Nanotechnology is not medicine. The ideal goal of regenerative medicine is the in only an excellent tool to produce material structures that vivo regeneration or, alternatively, the in vitro generation mimic the biological ones but also holds the promise of of a complex functional organ consisting of a scaffold made providing efficient delivery systems.
    [Show full text]
  • Cancer Nanomedicine: from Targeted Delivery to Combination Therapy
    Review Cancer nanomedicine: from targeted delivery to combination therapy 1,2,3 1 1 1,2 Xiaoyang Xu , William Ho , Xueqing Zhang , Nicolas Bertrand , and 1 Omid Farokhzad 1 Laboratory of Nanomedicine and Biomaterials, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA 2 The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA 3 Department of Chemical, Biological and Pharmaceutical Engineering, New Jersey Institute of Technology, Newark, NJ 07102, USA The advent of nanomedicine marks an unparalleled op- advantages of NPs have brought widespread attention to portunity to advance the treatment of various diseases, the field of nanomedicine, including their large ratio of including cancer. The unique properties of nanoparticles volume to surface area, modifiable external shell, biode- (NPs), such as large surface-to-volume ratio, small size, gradability, and low cytotoxicity [4]. Furthermore, nano- the ability to encapsulate various drugs, and tunable medicine brings us dramatically closer to realizing the full surface chemistry, give them many advantages over their promise of personalized medicine [5]. bulk counterparts. This includes multivalent surface mod- Engineered therapeutic NPs offer numerous clinical ification with targeting ligands, efficient navigation of the advantages. Surface modification with polyethylene glycol complex in vivo environment, increased intracellular traf- (PEG) protects NPs from clearance from the blood by the ficking, and sustained release of drug payload. These mononuclear phagocytic system (MPS), markedly increasing advantages make NPs a mode of treatment potentially both circulation times and drug uptake by target cells superior to conventional cancer therapies. This review [2,6].
    [Show full text]
  • COVID-19 Publications - Week 22 2020 709 Publications
    Update May 25 - May 31, 2020, Dr. Peter J. Lansberg MD, PhD Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics COVID-19 publications - Week 22 2020 709 Publications PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected] Reliable on-line resources for Covid 19 WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker AAN - Neurology resources COVID-19 resources (Harvard) COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers,
    [Show full text]
  • Personalized Nanomedicine
    Published OnlineFirst July 24, 2012; DOI: 10.1158/1078-0432.CCR-12-1414 Clinical Cancer Perspective Research Personalized Nanomedicine Twan Lammers1,2,3, Larissa Y. Rizzo1, Gert Storm2,3, and Fabian Kiessling1 Abstract Personalized medicine aims to individualize chemotherapeutic interventions on the basis of ex vivo and in vivo information on patient- and disease-specific characteristics. By noninvasively visualizing how well image-guided nanomedicines—that is, submicrometer-sized drug delivery systems containing both drugs and imaging agents within a single formulation, and designed to more specifically deliver drug molecules to pathologic sites—accumulate at the target site, patients likely to respond to nanomedicine-based therapeutic interventions may be preselected. In addition, by longitudinally monitoring how well patients respond to nanomedicine-based therapeutic interventions, drug doses and treatment protocols can be individualized and optimized during follow-up. Furthermore, noninvasive imaging information on the accumulation of nanomedicine formulations in potentially endangered healthy tissues may be used to exclude patients from further treatment. Consequently, combining noninvasive imaging with tumor-targeted drug delivery seems to hold significant potential for personalizing nanomedicine-based chemotherapeutic interventions, to achieve delivery of the right drug to the right location in the right patient at the right time. Clin Cancer Res; 18(18); 4889–94. Ó2012 AACR. Introduction Similarly, immunohistochemical tests evaluating the pro- Personalized medicine is often heralded as one of the tein expression levels of HER2, epidermal growth factor major leaps forward for 21st century medical practice (1). It receptor (EGFR), and c-kit in metastatic breast, colorectal, aims to individualize therapeutic interventions, incorpo- and gastrointestinal tumors, respectively, are approved by rating not only information obtained using ex vivo genetic the U.S.
    [Show full text]